tiprankstipranks
Talkspace, Inc. (TALK)
NASDAQ:TALK
US Market
Want to see TALK full AI Analyst Report?

Talkspace (TALK) Stock Forecast & Price Target

645 Followers
See the Price Targets and Ratings of:

TALK Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Talkspace
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TALK Stock 12 Month Forecast

There Are No Analyst Ratings for TALK In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

TALK Financial Forecast

TALK Earnings Forecast

The previous quarter’s earnings for TALK were >-$0.01.
The previous quarter’s earnings for TALK were >-$0.01.

TALK Sales Forecast

The previous quarter’s earnings for TALK were $61.67M.
The previous quarter’s earnings for TALK were $61.67M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on TALK
Canaccord Genuity
Canaccord Genuity
$5.25
Hold
0.77%
Upside
Reiterated
05/12/26
Talkspace: Hold Rating Reiterated as Analyst Keeps $5.25 Price Target Amid UHS Acquisition Progress
Northland Securities Analyst forecast on TALK
Northland Securities
Northland Securities
$5.25
Hold
0.77%
Upside
Assigned
03/10/26
Talkspace: Hold Rating as Takeout Valuation Caps Upside at $5.25 per Share
Barclays
$5.5$5.25
Hold
0.77%
Upside
Reiterated
03/10/26
Barclays Sticks to Its Hold Rating for Talkspace (TALK)
KeyBanc
Hold
Reiterated
03/10/26
Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (NASDAQ: ZVRA), Jazz Pharmaceuticals (NASDAQ: JAZZ) and Talkspace (NASDAQ: TALK)
William Blair Analyst forecast on TALK
William Blair
William Blair
Hold
Downgraded
03/09/26
Talkspace downgraded to Market Perform from Outperform at William BlairTalkspace downgraded to Market Perform from Outperform at William Blair
Needham
Hold
Downgraded
03/09/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Mirum Pharmaceuticals (NASDAQ: MIRM) and Talkspace (NASDAQ: TALK)
TD Cowen
$6$9
Buy
72.74%
Upside
Reiterated
02/20/26
Talkspace: Sustained Payor-Driven Growth and Emerging AI Upside Support Buy Rating
Mizuho Securities Analyst forecast on TALK
Mizuho Securities
Mizuho Securities
$4$6
Buy
15.16%
Upside
Reiterated
02/20/26
Talkspace price target raised to $6 from $4 at MizuhoTalkspace price target raised to $6 from $4 at Mizuho
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on TALK
Canaccord Genuity
Canaccord Genuity
$5.25
Hold
0.77%
Upside
Reiterated
05/12/26
Talkspace: Hold Rating Reiterated as Analyst Keeps $5.25 Price Target Amid UHS Acquisition Progress
Northland Securities Analyst forecast on TALK
Northland Securities
Northland Securities
$5.25
Hold
0.77%
Upside
Assigned
03/10/26
Talkspace: Hold Rating as Takeout Valuation Caps Upside at $5.25 per Share
Barclays
$5.5$5.25
Hold
0.77%
Upside
Reiterated
03/10/26
Barclays Sticks to Its Hold Rating for Talkspace (TALK)
KeyBanc
Hold
Reiterated
03/10/26
Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (NASDAQ: ZVRA), Jazz Pharmaceuticals (NASDAQ: JAZZ) and Talkspace (NASDAQ: TALK)
William Blair Analyst forecast on TALK
William Blair
William Blair
Hold
Downgraded
03/09/26
Talkspace downgraded to Market Perform from Outperform at William BlairTalkspace downgraded to Market Perform from Outperform at William Blair
Needham
Hold
Downgraded
03/09/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Mirum Pharmaceuticals (NASDAQ: MIRM) and Talkspace (NASDAQ: TALK)
TD Cowen
$6$9
Buy
72.74%
Upside
Reiterated
02/20/26
Talkspace: Sustained Payor-Driven Growth and Emerging AI Upside Support Buy Rating
Mizuho Securities Analyst forecast on TALK
Mizuho Securities
Mizuho Securities
$4$6
Buy
15.16%
Upside
Reiterated
02/20/26
Talkspace price target raised to $6 from $4 at MizuhoTalkspace price target raised to $6 from $4 at Mizuho
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Talkspace

3 Months
Success Rate
10/19 ratings generated profit
53%
Average Return
+10.97%
Copying Charles Rhyee's trades and holding each position for 3 Months would result in 52.63% of your transactions generating a profit, with an average return of +10.97% per trade.
1 Year
Success Rate
16/19 ratings generated profit
84%
Average Return
+59.37%
Copying Charles Rhyee's trades and holding each position for 1 Year would result in 84.21% of your transactions generating a profit, with an average return of +59.37% per trade.
2 Years
Success Rate
18/19 ratings generated profit
95%
Average Return
+89.99%
Copying Charles Rhyee's trades and holding each position for 2 Years would result in 94.74% of your transactions generating a profit, with an average return of +89.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TALK Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
2
0
0
0
0
Buy
5
0
0
0
0
Hold
7
7
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
7
1
1
0
In the current month, TALK has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TALK average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

TALK Stock Forecast FAQ

What is TALK’s average 12-month price target, according to analysts?
Currently, no data Available
What is TALK’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TALK, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is TALK a Buy, Sell or Hold?
      Currently, no data Available
      What is Talkspace, Inc.’s price target?
      Currently, no data Available
      What do analysts say about Talkspace, Inc.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of TALK?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.